ATAI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Atai Life Sciences Nv (ATAI).


$223.18M Market Cap.

As of 03/17/2025 5:00 PM ET (MRY) • Disclaimer

ATAI Market Cap. (MRY)


ATAI Shares Outstanding (MRY)


ATAI Assets (MRY)


Total Assets

$159.39M

Total Liabilities

$42.83M

Total Investments

$125.79M

ATAI Income (MRY)


Revenue

$308.00K

Net Income

-$149.27M

Operating Expense

$103.00M

ATAI Cash Flow (MRY)


CF Operations

-$82.44M

CF Investing

$59.17M

CF Financing

$5.37M

ATAI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

ATAI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$159,387,000 (-45.69%)

$293,478,000 (-3.92%)

$305,441,000 (-26.25%)

$414,166,000 (271.29%)

Assets Current

$80,125,000 (-56.83%)

$185,592,000 (-35.37%)

$287,145,000 (-23.44%)

$375,082,000 (276.79%)

Assets Non-Current

$79,262,000 (-26.53%)

$107,886,000 (489.67%)

$18,296,000 (-53.19%)

$39,084,000 (225.70%)

Goodwill & Intangible Assets

$3,577,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$116,297,000 (-52.13%)

$242,962,000 (-6.82%)

$260,740,000 (-30.82%)

$376,908,000 (315.00%)

Property Plant & Equipment Net

$3,869,000 (75.54%)

$2,204,000 (90.99%)

$1,154,000 (674.50%)

$149,000 (109.86%)

Cash & Equivalents

$17,505,000 (-61.13%)

$45,034,000 (-76.37%)

$190,613,000 (-47.38%)

$362,266,000 (272.53%)

Accumulated Other Comprehensive Income

-$18,466,000 (5.11%)

-$19,460,000 (10.33%)

-$21,702,000 (-160.34%)

-$8,336,000 (-243.25%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$125,791,000 (-47.08%)

$237,690,000 (146.28%)

$96,513,000 (196.90%)

$32,507,000 (217.42%)

Investments Current

$54,825,000 (-59.31%)

$134,728,000 (63.31%)

$82,496,000 (8935.71%)

$913,000 (303.98%)

Investments Non-Current

$70,966,000 (-31.08%)

$102,962,000 (634.55%)

$14,017,000 (-55.63%)

$31,594,000 (215.47%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,616,000 (-42.99%)

$4,589,000 (91.29%)

$2,399,000 (-60.04%)

$6,004,000 (94.75%)

Accumulated Retained Earnings (Deficit)

-$700,207,000 (-27.09%)

-$550,938,000 (-7.99%)

-$510,188,000 (-42.59%)

-$357,803,000 (-88.32%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$24,706,000 (29.07%)

$19,142,000 (24.78%)

$15,341,000 (1964.74%)

$743,000 (-65.87%)

Debt Current

$9,841,000 (3478.55%)

$275,000 (52.78%)

$180,000 (0%)

$0 (0%)

Debt Non-Current

$14,865,000 (-21.21%)

$18,867,000 (24.44%)

$15,161,000 (1940.51%)

$743,000 (-65.87%)

Total Liabilities

$42,833,000 (-12.87%)

$49,162,000 (23.91%)

$39,675,000 (40.66%)

$28,207,000 (74.33%)

Liabilities Current

$24,951,000 (24.01%)

$20,120,000 (1.12%)

$19,897,000 (-4.96%)

$20,935,000 (70.23%)

Liabilities Non-Current

$17,882,000 (-38.43%)

$29,042,000 (46.84%)

$19,778,000 (171.97%)

$7,272,000 (87.33%)

ATAI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$308,000 (-1.91%)

$314,000 (34.76%)

$233,000 (-98.86%)

$20,376,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$47,544,000 (-25.22%)

$63,582,000 (-9.62%)

$70,350,000 (-24.15%)

$92,745,000 (14.88%)

Research & Development Expense

$55,455,000 (-10.85%)

$62,203,000 (-16.30%)

$74,313,000 (54.96%)

$47,956,000 (320.37%)

Operating Expenses

$102,999,000 (-18.12%)

$125,785,000 (-13.26%)

$145,020,000 (-7.15%)

$156,181,000 (49.94%)

Interest Expense

$3,124,000 (17.62%)

$2,656,000 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

-$356,000 (-135.04%)

$1,016,000 (-83.69%)

$6,229,000 (256.15%)

-$3,989,000 (-1407.87%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$150,049,000 (-241.84%)

-$43,895,000 (72.12%)

-$157,417,000 (9.66%)

-$174,244,000 (2.45%)

Net Income to Non-Controlling Interests

-$780,000 (78.75%)

-$3,671,000 (27.05%)

-$5,032,000 (21.81%)

-$6,436,000 (26.71%)

Net Income

-$149,269,000 (-271.09%)

-$40,224,000 (73.60%)

-$152,385,000 (9.19%)

-$167,808,000 (1.20%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$149,269,000 (-271.09%)

-$40,224,000 (73.60%)

-$152,385,000 (9.19%)

-$167,808,000 (1.20%)

Weighted Average Shares

$160,159,983 (0.83%)

$158,833,785 (2.00%)

$155,719,585 (12.62%)

$138,265,859 (48.64%)

Weighted Average Shares Diluted

$160,159,983 (0.83%)

$158,833,785 (2.00%)

$155,719,585 (12.62%)

$138,265,859 (48.64%)

Earning Before Interest & Taxes (EBIT)

-$146,501,000 (-300.80%)

-$36,552,000 (74.99%)

-$146,156,000 (14.93%)

-$171,797,000 (-1.33%)

Gross Profit

$308,000 (-1.91%)

$314,000 (34.76%)

$233,000 (-98.86%)

$20,376,000 (0%)

Operating Income

-$102,691,000 (18.16%)

-$125,471,000 (13.34%)

-$144,787,000 (-6.61%)

-$135,805,000 (-30.38%)

ATAI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$59,172,000 (211.03%)

-$53,295,000 (38.63%)

-$86,848,000 (-6.86%)

-$81,276,000 (-187.49%)

Net Cash Flow from Financing

$5,374,000 (164.32%)

-$8,355,000 (-140.20%)

$20,785,000 (-94.93%)

$409,862,000 (262.54%)

Net Cash Flow from Operations

-$82,437,000 (2.00%)

-$84,118,000 (19.48%)

-$104,467,000 (-65.18%)

-$63,246,000 (-204.57%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$17,529,000 (87.96%)

-$145,578,000 (15.19%)

-$171,653,000 (-164.77%)

$265,020,000 (294.47%)

Net Cash Flow - Business Acquisitions and Disposals

-$7,386,000 (-23.99%)

-$5,957,000 (0%)

$0 (0%)

-$953,000 (-2006.00%)

Net Cash Flow - Investment Acquisitions and Disposals

$66,653,000 (242.58%)

-$46,749,000 (45.53%)

-$85,824,000 (-8.37%)

-$79,195,000 (-183.61%)

Capital Expenditure

-$12,000 (97.97%)

-$590,000 (42.38%)

-$1,024,000 (9.22%)

-$1,128,000 (-1811.86%)

Issuance (Repayment) of Debt Securities

$5,000,000 (5100.00%)

-$100,000 (-100.67%)

$15,000,000 (274.53%)

$4,005,000 (-87.68%)

Issuance (Purchase) of Equity Shares

$535,000 (160.98%)

$205,000 (-91.06%)

$2,294,000 (-99.44%)

$411,353,000 (398.25%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$362,000 (91.53%)

$189,000 (116.83%)

-$1,123,000 (-250.94%)

-$320,000 (-110.10%)

Share Based Compensation

$25,490,000 (-22.72%)

$32,982,000 (-22.17%)

$42,375,000 (-33.12%)

$63,362,000 (-5.65%)

Depreciation Amortization & Accretion

$889,000 (26.64%)

$702,000 (317.86%)

$168,000 (257.45%)

$47,000 (95.83%)

ATAI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-48464.00% (-278.32%)

-12810.20% (80.41%)

-65401.30% (-7840.91%)

-823.60%

EBITDA Margin

-47276.60% (-314.08%)

-11417.20% (81.78%)

-62655.80% (-7333.36%)

-842.90%

Return on Average Equity (ROAE)

-91.50% (-444.64%)

-16.80% (66.73%)

-50.50% (-6.54%)

-47.40% (79.13%)

Return on Average Assets (ROAA)

-70.90% (-399.30%)

-14.20% (67.80%)

-44.10% (-1.85%)

-43.30% (77.86%)

Return on Sales (ROS)

-47565.30% (-308.61%)

-11640.80% (81.44%)

-62727.90% (-7340.15%)

-843.10%

Return on Invested Capital (ROIC)

-76.70% (-256.74%)

-21.50% (71.26%)

-74.80% (85.28%)

-508.30% (47.86%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-1.43 (74.65%)

-5.64 (-107.81%)

-2.71 (56.96%)

-6.31

Price to Sales Ratio (P/S)

691.6 (-3.03%)

713.23 (-59.88%)

1,777.74 (3333.59%)

51.77

Price to Book Ratio (P/B)

1.92 (99.27%)

0.96 (-43.09%)

1.69 (-47.86%)

3.25

Debt to Equity Ratio (D/E)

0.37 (82.18%)

0.2 (32.89%)

0.15 (102.67%)

0.07 (-57.87%)

Earnings Per Share (EPS)

-0.93 (-272.00%)

-0.25 (74.49%)

-0.98 (19.01%)

-1.21 (33.88%)

Sales Per Share (SPS)

0 (0.00%)

0 (100.00%)

0 (-99.32%)

0.15 (0%)

Free Cash Flow Per Share (FCFPS)

-0.52 (3.38%)

-0.53 (21.27%)

-0.68 (-45.28%)

-0.47 (-108.04%)

Book Value Per Share (BVPS)

0.73 (-52.55%)

1.53 (-8.60%)

1.67 (-38.59%)

2.73 (179.30%)

Tangible Assets Book Value Per Share (TABVPS)

0.97 (-47.35%)

1.85 (-5.76%)

1.96 (-34.52%)

3 (149.79%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (80.00%)

-5 (-150.00%)

-2 (60.00%)

-5

Enterprise Value Over EBITDA (EV/EBITDA)

-1.49 (69.35%)

-4.86 (-126.20%)

-2.15 (53.49%)

-4.62

Asset Turnover

0 (0.00%)

0 (0.00%)

0 (-98.11%)

0.05 (0%)

Current Ratio

3.21 (-65.19%)

9.22 (-36.09%)

14.43 (-19.45%)

17.92 (121.33%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$82,449,000 (2.67%)

-$84,708,000 (19.70%)

-$105,491,000 (-63.87%)

-$64,374,000 (-209.12%)

Enterprise Value (EV)

$217,021,187 (24.54%)

$174,251,771 (-44.45%)

$313,690,317 (-60.47%)

$793,603,374

Earnings Before Tax (EBT)

-$149,625,000 (-281.62%)

-$39,208,000 (73.17%)

-$146,156,000 (14.93%)

-$171,797,000 (-1.33%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$145,612,000 (-306.17%)

-$35,850,000 (75.44%)

-$145,988,000 (15.00%)

-$171,750,000 (-1.32%)

Invested Capital

$138,060,000 (-44.21%)

$247,466,000 (124.41%)

$110,272,000 (247.77%)

$31,708,000 (658.38%)

Working Capital

$55,174,000 (-66.66%)

$165,472,000 (-38.08%)

$267,248,000 (-24.54%)

$354,147,000 (305.90%)

Tangible Asset Value

$155,810,000 (-46.91%)

$293,478,000 (-3.92%)

$305,441,000 (-26.25%)

$414,166,000 (271.29%)

Market Capitalization

$223,177,187 (-4.66%)

$234,074,771 (-46.95%)

$441,228,317 (-63.92%)

$1,223,073,374

Average Equity

$163,112,750 (-31.94%)

$239,653,250 (-20.63%)

$301,955,000 (-14.72%)

$354,083,500 (373.46%)

Average Assets

$210,451,250 (-25.90%)

$284,002,500 (-17.72%)

$345,176,500 (-10.89%)

$387,374,250 (346.12%)

Invested Capital Average

$191,065,250 (12.55%)

$169,759,500 (-13.09%)

$195,318,750 (477.90%)

$33,798,250 (94.33%)

Shares

167,802,396 (1.08%)

166,010,476 (0.08%)

165,875,307 (3.48%)

160,297,952 (5.56%)